151 related articles for article (PubMed ID: 21316756)
21. Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice.
Kulkarni R; Sapkal G; Gore M
Virus Res; 2012 Dec; 170(1-2):118-25. PubMed ID: 23007095
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.
Muangchana C; Henprasertthae N; Nurach K; Theppang K; Yoocharoen P; Varinsathien P; Techathawat S; Sanohsieng S; Anantapreecha S
Vaccine; 2012 Jan; 30(2):361-7. PubMed ID: 22075090
[TBL] [Abstract][Full Text] [Related]
23. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
[TBL] [Abstract][Full Text] [Related]
24. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
Fan YC; Chen JM; Chiu HC; Chen YY; Lin JW; Shih CC; Chen CM; Chang CC; Chang GJ; Chiou SS
PLoS Negl Trop Dis; 2012; 6(9):e1834. PubMed ID: 23029592
[TBL] [Abstract][Full Text] [Related]
25. Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows.
Imoto J; Ishikawa T; Yamanaka A; Konishi M; Murakami K; Shibahara T; Kubo M; Lim CK; Hamano M; Takasaki T; Kurane I; Udagawa H; Mukuta Y; Konishi E
Vaccine; 2010 Oct; 28(46):7373-80. PubMed ID: 20851083
[TBL] [Abstract][Full Text] [Related]
26. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
Halstead SB; Thomas SJ
Expert Rev Vaccines; 2011 Mar; 10(3):355-64. PubMed ID: 21434803
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis.
Zhao F; Zhai Y; Zhu J; Xiao P; Feng G
Vaccine; 2019 Sep; 37(37):5588-5595. PubMed ID: 31399273
[TBL] [Abstract][Full Text] [Related]
28. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
Kitai Y; Kondo T; Konishi E
J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
[TBL] [Abstract][Full Text] [Related]
29. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081
[TBL] [Abstract][Full Text] [Related]
30. Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice.
Tafuku S; Miyata T; Tadano M; Mitsumata R; Kawakami H; Harakuni T; Sewaki T; Arakawa T
Microbes Infect; 2012 Feb; 14(2):169-76. PubMed ID: 22001496
[TBL] [Abstract][Full Text] [Related]
31. Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune response.
Wang F; Feng X; Zheng Q; Hou H; Cao R; Zhou B; Liu Q; Liu X; Pang R; Zhao J; Deng W; Chen P
Virol J; 2012 Sep; 9():204. PubMed ID: 22985466
[TBL] [Abstract][Full Text] [Related]
32. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
33. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III].
Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W
Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Immune Responses Against Japanese Encephalitis Virus Infection Using Japanese Encephalitis Live-Attenuated Virus Adjuvanted with Montanide GEL 01 ST in Mice.
Xu Y; Wang Q; Wei B; Huang X; Wen Y; Yan Q; Ma X; Zhao Q; Cao S; Huang Y; Wen X; Han X; Bai Y; Wu R
Vector Borne Zoonotic Dis; 2019 Nov; 19(11):835-843. PubMed ID: 31314706
[TBL] [Abstract][Full Text] [Related]
35. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
[TBL] [Abstract][Full Text] [Related]
36. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
NAM JH; BANG HS; CHO HW; CHUNG YH
Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
[TBL] [Abstract][Full Text] [Related]
37. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity.
Xu G; Xu X; Li Z; He Q; Wu B; Sun S; Chen H
Vaccine; 2004 May; 22(15-16):1846-53. PubMed ID: 15121294
[TBL] [Abstract][Full Text] [Related]
38. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
[TBL] [Abstract][Full Text] [Related]
39. Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination.
Gao N; Chen W; Zheng Q; Fan DY; Zhang JL; Chen H; Gao GF; Zhou DS; An J
Immunol Lett; 2010 Mar; 129(1):23-31. PubMed ID: 20064558
[TBL] [Abstract][Full Text] [Related]
40. Development of a recombinant vaccine against Japanese encephalitis.
Kaur R; Vrati S
J Neurovirol; 2003 Aug; 9(4):421-31. PubMed ID: 12907387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
